0 0
Read Time:4 Minute, 33 Second

With the aid of a tube that goes straight to the stomach or small intestine, enteral feeding systems are used to ingest food through the G.I. tract. Patients who struggle to consume sufficient calories but have an adequate gastrointestinal function to support digestion and absorption are encouraged to use these devices. In critical care units (CCU), operating rooms (O.T.), intensive care units (ICU), and even at-home care settings, enteral feeding systems are widely used.

The market value of enteral feeding devices in 2021 was USD 3.48 billion, and it will be USD 6.088 billion by 2030 at a 6.38% CAGR.

The rising rate of chronic diseases such as cancer and neurological disorders such as stroke, multiple sclerosis, and dementia is driving market expansion. The growing senior population and the increasing number of malnourished persons will increase the use of enteral feeding systems. 

Market Dynamics


Increasing preference for enteral feeding devices over parenteral devices

The ease of usage has led to an increase in enteral feeding systems. Better feeding methods and quicker patient recovery have been made possible by the invention of enteral feeding devices. The provision of necessary nutrients via the digestive system constitutes eternal feeding. Parenteral nutrition is delivered through the peripheral route. It includes inserting a catheter to supply nutrition and drugs intravenously. Parenteral feeding methods are inconvenient for the patient, whereas enteral feeding devices are. An enteral feeding device is significantly less expensive than a parenteral feeding system. In a variety of therapeutic approaches, enteral feeding systems are being used more frequently.


When using enteral feeding systems, patients might experience specific difficulties. The most frequent side effects are diarrhea, abdominal infections, dehydration, and constipation. Enteral feeding equipment needs to be efficiently and correctly maintained to prevent difficulties. As a result, it prevents the market for enteral feeding systems from expanding.


The rising rate of chronic conditions such as orthopedic, cardiovascular, and neurovascular diseases has raised awareness of the benefits of enteral feeding systems, particularly among the working and geriatric populations. The illnesses’ predominance may lead to lifestyle alterations and worsen the patient’s health. Additionally, the persistence of such illnesses may make it difficult for the patient to swallow, digest their meals, or absorb nutrients, all of which can be very uncomfortable. Enteral feeding systems are the most efficient approach to provide nutrition to individuals who have trouble absorbing nutrients.

Market Segmentation

Product Analysis

On the basis of product, the market for enteral feeding devices is segmented into gastrostomy tubes, giving sets, enteral feeding pumps, percutaneous endoscopic gastrostomy devices, low-profile gastrostomy devices, nasogastric tubes, and others.

In 2021, the enteral feeding pump market segment generated a maximum market share of 40.0%. For individuals with chronic illnesses, enteral feeding pumps are necessary. When this occurs, the body struggles to absorb the nutrients that enteral feeding pumps are used to deliver. In order to prevent the patient’s body from becoming weak, feeding pumps guarantee proper nourishment intake.

Application Analysis 

On the basis of application, the market for enteral feeding devices is segmented into cancer, diabetes, neurological disorders, and others.

The cancer segment held the maximum market with a revenue share of 45% in 2020 due to the increasing number of cancer cases, specifically in neck & head, gastrointestinal, liver, and lung cancer, among others. As per National Center for Biotechnology Information, there were 19.3 million new cancer cases worldwide in 2020. According to ACS Journals, there were 1,806,590 cancer cases in the United States in 2020, with digestive system cancer accounting for the majority of cases (333,680 or roughly 18.47%).

Age Group Analysis

On the basis of age group, the enteral feeding devices market segment comprises adults, pediatrics, and children.

In 2021, the adult segment maintained the largest market position, with 66.09% of the share. The geriatric population is prone to chronic illnesses like neurological problems, gastrointestinal diseases, and hypermetabolism. The incidence of chronic disorders has increased dramatically as people’s ages have increased.

End-User Analysis

On the basis of end-user, the market is segmented into ambulatory surgical centers, hospitals, and home care.

The hospital segment led the market with a maximum share of 47.54% in 2021. Due to a large number of patients being hospitalized, hospitals are using more enteral feeding systems. Enteral feeding devices are used during general and specialty operations because most patients cannot absorb nutrients.

Regional Analysis

North America held a significant market position in 2021, with the largest share of 40.09%. The biggest share is due to a huge number of market participants, the rise in the occurrence of chronic diseases, increased knowledge of the enteral method, and ongoing support from the U.S. and Canadian governments.

Additionally, Asia Pacific will grow at a robust CAGR. The region’s market size will benefit from the rise in the percentage of the population that suffers from malnutrition, the rise in the number of manufacturers specializing in enteral feeding devices, and the rise in the number of general surgeries.

Key Players

  • Boston Scientific Corporation 
  • Becton, Dickinson, and Company
  • CONMED Corporation
  • Danone S.A.
  • Cardinal Health Inc.
  • Fresenius Kabi
  • Vygon Group
  • Moog Inc.
  • Cook Medical
  • Nestlé S.A.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Avanos Medical Inc
  • Amsino International Inc.
  • Danumed Medizintechnik
  • Fuji Systems CorporationOmex Medical Technology
  • Medline Industries, Inc.
  • Vesco Medical LLC
  • Medela Inc.
  • Applied Medical Technology 
  • Kentec Medical Inc.
  • Dynarex Corporation
  • Alcor Scientific
0 %
0 %
0 %
0 %
0 %
0 %